Showing results (101-110 of 127) with videos related to
Sort By:
Pageof 13
Oncology (Williston Park, N.Y.)|June 13, 2003
Phase I. Trial of irinotecan plus carboplatin in two dose schedulesSuzanne F Jones, Howard A Burris, John D Hainsworth, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2011
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancerDavid R Spigel, John D Hainsworth, Dianna L Shipley, et al.Clinical Lung Cancer|June 10, 2005
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancerSuzanne F Jones, John G Kuhn, F Anthony Greco, et al.Cancer Journal (Sudbury, Mass.)|February 19, 2010
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium TrialJohn D Hainsworth, David R Spigel, Bobby L Clark, et al.Oncology (Williston Park, N.Y.)|June 13, 2003
Phase I. Trial of irinotecan and temozolomide in patients with solid tumorsSuzanne F Jones, Victor G Gian, F Anthony Greco, et al.Cancer Journal (Sudbury, Mass.)|September 12, 2003
Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trialAnthony A Meluch, F Anthony Greco, James R Gray, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluationGauri R Varadhachary, Dmitri Talantov, Martin N Raber, et al.Cancer Journal (Sudbury, Mass.)|August 20, 2002
Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Anthony A Meluch, Suzanne McClurkan, et al.Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancerDavid R Spigel, F Anthony Greco, David Waterhouse, et al.JCO Precision Oncology|September 4, 2024
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown PrimaryHarry E Fuentes Bayne, Pashtoon M Kasi, Li Ma, et al.Pageof 13